Variant Bio leverages human genetic diversity to develop life-saving therapies, focusing on understanding how genes influence health traits. The company integrates genetics, drug discovery, molecular biology, anthropology, and ethics to advance genomic drug discovery and partnerships worldwide. Based in Seattle, Variant Bio highlights ethical engagement and benefit-sharing with partner communities as a core principle of its research model. Its work aims to transform drug development by using human genetics to identify molecular targets and improve clinical outcomes.